Diabetes and chronic kidney disease: Lessons from renal epidemiology;Diabète et maladie rénale chronique : ce que nous apprend l'épidémiologie

Nephrologie et Therapeutique

Volumn 6, Issue 7, 2010, Pages 585-590

  Villar, Emmanuel ^a   Zaoui, Philippe ^b  

^a HOSPICES CIVILS DE LYON   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Chronic kidney disease; Diabetic nephropathy; End stage renal disease; Epidemiology; Gender; Incidence; Prevalence; Survival; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ARTICLE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EPIDEMIC; FRANCE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROGNOSIS;

EID: 78649971308     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2010.08.002     Document Type: Short Survey

References (65)

1. E. Ritz, I. Rychlik, F. Locatelli, and S. Halimi End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions Am J Kidney Dis 34 1999 795 808
2. http://www.usrds.org.
3. http://www.anzdata.com.au.
4. http://www.era-edta-reg.org.
5. http://www.agence-biomedecine.fr/uploads/document/Rapport-REIN-2008-couv. pdf.
6. van Dijk PC, Jager KJ, Stengel B, Grönhagen-Riska C, Feest TG, Briggs JD. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 2005;67:1489-99.
7. C. Couchoud, E. Villar, L. Frimat, A. Fagot-Campagna, and B. Stengel L'insuffisance rénale chronique terminale associée un diabte : fréquence et conditions d'initiation du traitement de suppléance, France, 2006 Bull Epidemiol Hebd 43 2008 414 418
8. E. Villar, S.H. Chang, and S.P. McDonald Incidences, treatments, outcomes, and gender effect on survival in end-stage renal disease patients by diabetic status in Australia and New Zealand (1995-2005) Diabetes Care 30 12 2007 3070 3076
9. E. Villar, K. Polkinghorne, S.H. Chang, S.J. Chadban, and S.P. McDonald Effect of type 2 diabetes on mortality risk associated with end-stage renal disease Diabetologia 52 2009 2536 2541
10. V.R. Sorensen, E.R. Mathiesen, J. Heaf, and B. Feldt-Rasmussen Improved survival rate in patients with diabetes and end-stage renal disease in Denmark Diabetologia 50 2007 922 929
11. M. Kervinen, S. Lehto, R. Ikäheimo, P. Karhapää, C. Grönhagen-Riska, and P. Finne Improved survival of type 2 diabetic patients on renal replacement therapy in Finland Nephrol Dial Transplant 25 2010 892 896
12. M. Haapio, J. Helve, P.H. Groop, C. Grönhage-Riska, and P. Finne Survival of patients with type 1 diabetes on renal replacement therapy in 1980-2007 Diabetes Care 33 2010 1718 1723
13. Groupe de travail de la Société de néphrologie, Commission d'épidémiologie Évaluation de la fonction rénale et de la protéinurie pour le diagnostic de la maladie rénale chronique chez l'adulte. Recommandations pour la pratique clinique Nephrol Ther 5 2009 302 305
14. P. Fioretto, M.L. Caramori, and M. Mauer The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007 Diabetologia 51 2008 1347 1355
15. G. Mazzucco, T. Bertani, and M. Fortunato Different patterns of renal damage in Type 2 diabetes mellitus: a multicentric study on 393 biopsies Am J Kidney Dis 39 2002 713 720
16. T.W. Cohen Tervaert, A.L. Mooyaart, and K. Amann Pathologic classification of diabetic nephropathy J Am Soc Nephrol 21 2010 556 563
17. N.R. Burrows, Y. Li, and L.S. Geiss Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline Diabetes Care 33 2010 73 77
18. O. Kusnik-Joinville, A. Weill, P. Ricordeau, and H. Allemand Diabte traité en France en 2007 : un taux de prévalence proche de 4 % et des disparités géographiques croissantes Bull Epidemiol Hebd 43 2008 409 413
19. A. Fagot-Compagna, S. Fosse, and C. Roudier Caractéristiques, risque vasculaire et complications chez les personnes diabétiques en France métropolitaine : d'importantes évolutions entre Entred 2001 et Entred 2007 Bull Epidemiol Hebd 42-43 2010 450 455
20. C. Couchoud, M. Lassalle, B. Stengel, and C. Jacquelinet Registre REIN : rapport annuel 2007 Nephrol Ther 5 Suppl. 1 2009 S3 S144
21. E. Villar, S.P. McDonald, and C. Couchoud Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Response to Burrows, Li, and Geiss Diabetes Care 33 2010 e69
22. A. Haynes, C. Bower, M.K. Bulsara, JonesTW, and E.A. Davis Continued increase in the incidence of childhood type 1 diabetes in a population-based Australian sample (1985-2002) Diabetologia 47 2004 866 870
23. A.S. Astrup, L. Tarnow, P. Rossing, PietraszekL, P.R. Hansen, and H.H. Parving Improved prognosis in type 1 diabetic patients with nephropathy Kidney Int 68 2005 1250 1257
24. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
25. World Health Organization World Atlas of Aging 1998 Kobe: WHO, Centre for Health Development
26. M.A. Allman-Farinelli, T. Chey, A.E. Bauman, T. Gill, and W.P. James Age, period and birth cohort effect on prevalence of overweight and obesity in Australian adults from 1990 to 2000 Eur J Clin Nutr 62 2008 898 907
27. L.L. Lipscombe, and J.E. Hux Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study Lancet 369 2007 750 756
28. D.J. Cordonnier, D. Zmirou, P.Y. Benhamou, S. Halimi, F. Ledoux, and J. Guiserix Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus. The case of mainland France and of overseas French territories Diabetologia 36 1993 1109 1112
29. S. Halimi, D. Zmirou, and P.Y. Benhamou Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas territories. A second national survey six years apart (UREMIDIAB 2 Study) Diabetes Metab 25 1999 507 512
30. E.L. Korn, B.I. Graubard, and D. Midthune Time-to-event analysis of longitudinal follow-up of a survey: choice of time-scale Am J Epidemiol 145 1997 72 80
31. M.J. Pencina, M.G. Larson, and R.B. D'Agostino Choice of time scale and its effect on significance of predictors in longitudinal studies Stat Med 26 2007 1343 1359
32. E. Villar, L. Frimat, R. Ecochard, and M. Labeeuw Spé cificités méthodologiques de l'analyse de survie des patients dialysés Nephrol Ther 4 2008 553 561
33. e réunion SN-SFD; 2009 [Abstract CO040].
34. T. Morioka, M. Emoto, and T. Tabata Glycémic control is a predictor of survival for diabetic patients on hemodialysis Diabetes Care 24 2001 909 913
35. T. Oomichi, M. Emoto, and T. Tabata Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis. A 7-year observational study Diabetes Care 29 2006 1496 1500
36. M.E. Williams, E. Lacson Jr., M. Teng, N. Ofsthun, and J.M. Lazarus Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival Kidney Int 70 2006 1503 1509
37. E. Villar, L. Remontet, M. Labeeuw, R. Ecochard on behalf of the Association régionale des néphrologues de Rhône-Alpes and the French Renal Information and Epidemiology Network registry Effect of age, sex and diabetes on excess death in end-stage renal failure J Am Soc Nephrol 18 2007 2125 2134
38. A. Karamé, M. Labeeuw, and P. Trolliet The impact of type 2 diabetes on mortality in end-stage renal disease patients differs between genders Nephron Clin Pract 112 2009 268 275
39. W.L. Lee, A.M. Cheung, D. Cape, and B. Zinman Impact of diabetes on coronary artery disease in women and men. A meta-analysis of prospective studies Diabetes Care 23 2000 962 968
40. R. Huxley, F. Barzi, and M. Woodward Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies BMJ 332 2006 73 78
41. W.E. Bloembergen, F.K. Port, E.A. Mauger, and R.A. Wolfe Causes of death in dialysis patients: racial and gender differences J Am Soc Nephrol 5 1994 1231 1242
42. B. Hocher, P. Kalk, M. Godes, L. Liefeldt, R. Ziebig, and J.P. Stasch Gender-dependent impact of risk factors for cardiovascular and non-cardiovascular mortality in end-stage renal disease patients on haemodialysis Kidney Blood Press Res 31 2008 360 366
43. L.T. Cheng, Y.L. Gao, J.P. Tian, Y. Gu, L. Zhang, and S.H. Bi Sex difference in the prevalence of left ventricular hypertrophy in dialysis patients Am J Nephrol 29 2009 398 405
44. S.H. Chung, D.C. Han, and H. Noh Risk factors for mortality in diabetic peritoneal dialysis patients Nephrol Dial Transplant 2010 10.1093/ndt/gfq233 [in press]
45. J.J. Carrero, R. de Mustert, and J. Axelsson Sex differences in the impact of diabetes on mortality in chronic dialysis patients Nephrol Dial Transplant 2010 10.1093/ndt/gfq386 [in press]
46. A. Szalat, and I. Raz Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women Diabetes Obes Metab 10 2008 1135 1156
47. Breslow NE, Day NA. Statistical methods in cancer research. The design and analysis of cohort study, vol. II. Lyon (France): International Agency for Research on Cancer; 1987. pp 65-99 [scientific publication 82].
48. D.W. Dunstan, P.Z. Zimmet, T.W. Welborn, A.J. Cameron, J. Shaw, and M. de Courten The Australian Diabetes Obesity and Lifestyle Study (AusDiab) - Methods and response rates Diabetes Res Clin Pract 57 2002 119 129
49. A.S. Levey, J.A. Beto, and B.E. Coronado Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease Am J Kidney Dis 32 1988 853 906
50. R.A. Wolfe, V.B. Ashby, and E.L. Milford Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant N Engl J Med 341 1999 1725 1730
51. S.P. McDonald, and G.R. Russ Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001 Nephrol Dial Transplant 17 2002 2212 2219
52. S. Bayat, L. Frimat, N. Thilly, C. Loos, S. Brianon, and M. Kessler Medical and non-medical determinants of access to renal transplant waiting list in a French community-based network of care Nephrol Dial Transplant 21 2006 2900 2907
53. E. Villar, M. Rabilloud, P. Berthoux, P. Vialtel, M. Labeeuw, and C. Pouteil-Noble A multicentre study of registration on renal transplantation waiting list of the elderly and patients with type 2 diabetes Nephrol Dial Transplant 19 2004 207 214
54. E. Ishimura, S. Okuno, and H. Taniwaki Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control Kidney Blood Press Res 31 2008 10 15
55. L. Frimat, C. Loos-Ayav, V. Panescu, N. Cordebar, S. Brianon, and M. Kessler Early referral to a nephrologist is associated with better outcomes in type 2 diabetes patients with end-stage renal disease Diabetes Metab 30 2004 67 74
56. E.J. Lewis, L.G. Hunsicker, and W.R. Clarke Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 2001 851 860
57. B.M. Brenner, M.E. Cooper, and D. de Zeeuw Effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 2001 861 869
58. H.H. Parving, H. Lehnert, and J. Brochner-Mortensen The effect of Irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 2001 870 878
59. A.E. Declves, and K. Sharma New pharmacological treatments for improving renal outcomes in diabetes Nat Rev Nephrol 6 2010 371 380
60. C. Tourette-Turgis, C. Isnard-Bagnis, and L. Pereira-Paulo L'éducation thérapeutique dans la maladie rénale chronique - le soignant pédagogue 2009 Édition Comment Dire [ISBN 978-2-914-472-04-3]
61. La télésanté : un nouvel atout au service de notre bien-être. Rapport Lasbordes, 12 novembre 2009 (http://www.sante-sports. gouv.fr/IMG/pdf/Rapport-Telesante-decembre-2009.pdf ).
62. H. Nivet, C. Maingourd, and F. Mignon Démographie des néphrologues en France en 2002 Nephrologie 24 2003 431 446
63. C. Zoccali Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective Kidney Int 70 2006 26 33
64. M.G. Pezzolesi, J. Skupien, J.C. Mychaleckyj, J.H. Warram, and A.S. Krolewski Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection Semin Nephrol 30 2010 126 140
65. http://www.agence-biomedecine.fr